CARTER WALLACE INC /DE/

Carter Wallace Inc. /DE/, operating under SIC guidance that once placed it among specialty chemical and consumer health producers, still centers its reputation on developing advanced personal care formulations, pharmaceutical intermediates, and hygiene-centric consumer staples; these core products primarily serve institutional buyers such as contract manufacturers, healthcare systems, and multisite retailers seeking consistent quality and compliance in regulated environments. With CIK 18000 anchoring its regulatory identity, the company navigates material risks that include volatile raw-material costs in the chemical supply chain, shifting FDA oversight of hygiene and over-the-counter offerings, and the operational strain of maintaining global compliance without the cushion of a public ticker symbol. Even as industry classifications remain ambiguous, the company’s reliance on differentiated technical expertise and a global sourcing network underscores its response to demands for traceability and sustainability. For the latest context on filings and disclosures that corroborate this profile, view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025